The CRISPR Miracle: The Survival of Baby KJ
Artikel konnten nicht hinzugefügt werden
Der Titel konnte nicht zum Warenkorb hinzugefügt werden.
Der Titel konnte nicht zum Merkzettel hinzugefügt werden.
„Von Wunschzettel entfernen“ fehlgeschlagen.
„Podcast folgen“ fehlgeschlagen
„Podcast nicht mehr folgen“ fehlgeschlagen
The CRISPR Miracle: The Survival of Baby KJ
-
Gesprochen von:
-
Von:
Send us Fan Mail
This episode details a historic medical achievement where a ten-month-old infant, KJ Muldoon, became the first person to receive a personalized CRISPR gene editing therapy. Born with CPS1 deficiency, a rare and often fatal metabolic disorder that causes toxic ammonia buildup, KJ was treated with a bespoke base editor designed to correct his specific genetic mutations. This groundbreaking "n-of-1" treatment was developed in just six months through a collaborative effort between the Children’s Hospital of Philadelphia, Penn Medicine, and the Innovative Genomics Institute. Following the infusions, the patient showed significant clinical improvement, allowing him to tolerate protein and avoid a high-risk liver transplant. Researchers view this success as a landmark milestone that proves the feasibility of rapidly scaling custom genetic interventions for thousands of other untreatable rare diseases. KJ has since been discharged from the hospital, marking a transformative shift toward a new era of precision medicine.
Support the show
Inside the Future with Maby
Insights. Innovation. Impact.